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STAT3 Mediates Autophagy and Extracellular Matrix Synthesis in Human
Glomerular Mesangial Cells Exposed to High Glucose
Y. S. Yang, W. L. N. Wang, C. Y. Chen, G. X. R. Gao, S. D. Sun
The First Hospital of China Medical University, Shenyang, Liaoning, China
Ojectives: To explore the effect of STAT3 pathway on the autophagy of hu-
man glomerular mesangial cells (HGMC) and expression of extracellular ma-
trix Collagen IV cultured in high glucose.
Methods: HGMC were cultured in normal (5 mmol/L) or high glucose
(30 mmol/l) for 12e72 hours, and then S3I-201 (an inhibitor of STAT3 activ-
ity) or STAT3-siRNA transfection were added into HGMC. STAT3, p-STAT3 and
autophagy marker proteins LC3 and p62 protein expression was evaluated by
western blot, autophagesomes was detected by electron microscopic and
the expression of collagen IV was detected by ELISA in each group.
Results: High glucose significantly reduced the generation of autophagosome
and altered expression of LC3 and p62 at 24 h (LC3 II/LC3I and LC3II
decreased, p62 increased obviously), consistently high glucose exposure
significantly increased protein levels of STAT3, p-STAT3 and collagen IV.
These changes were reversed by S3I - 201 or STAT3-siRNA transfection.
Conclusion: High glucose can inhibit autophagy activity of human glomerular
mesangial cells and induce up-regulation expression of Collagen-IV. Inhibi-
tion of STAT3 pathway can reduce the inhibition of autophagy activity and
synthesis of collagen IV by high glucose.Fig. 1 High glucose inhibits autophagy activity and induces STAT3 activa-
tion of human glomerular mesangial cells at 24 h.
Fig. 2 Inhibition of STAT3 pathway reduces the inhibition of autophagy
activity and synthesis of collagen IV by high glucose. (A, B) Autophagesomes
were detected by electron microscopic (*P < 0.01 vs control, #P < 0.05 vs
high glucose). (C) Analysis of stat3, p-stat3, LC3 and p62 by Western blot.
(D) Expression of Collagen IV was detected by ELISA (*P < 0.01 vs control,
##P < 0.01 vs high glucose).http://dx.doi.org/10.1016/j.hkjn.2015.08.0500212
Ursolic Acid Improves the Podocytes Injury Caused by High Glucose
Li Xu, Qiuling Fan
The First Hospital of China Medical University, Shenyang, Liaoning, China
Objective: Autophagy plays an important role in maintaining podocytes ho-
meostasis. Reduced autophagy may result in limited renal cell function dur-
ing exposure to high glucose. In this study, we investigated the effects of
ursolic acid (UA) on autophagy and podocytes injury induced by high glucose.
Methods:Conditionally immortalizedmurinepodocyteswerecultured inmedia
containing high glucose, and we determined the effect of the PI3K inhibitor
LY294002 and ursolic acid treatment on protein expression. miR-21 expression
was detected using RT-qPCR. Activation of the PTEN-PI3K/Akt/mTOR pathway,
expression of autophagy-associated proteins and expression of podocytes spe-
cific proteins were determined byWestern blot. Immunofluorescence was used
to monitor expression of podocytes specific proteins and LC3 accumulation.
Autophagosomes were observed using electron microscopy.
Results: During exposure to high glucose condition, autophagy was reduced
in podocytes. Increased miR-21 expression, decreased PTEN expression, and
activation of the PI3K/Akt/mTOR pathway were observed during exposure to
high glucose. Ursolic acid and LY294002 reduced podocytes injury through
autophagy rescue. Our data suggest ursolic acid inhibits miR-21 expression
and increases PTEN expression, thereby inhibiting Akt and mTOR and
restoring autophagy levels.
Conclusion: Our data suggest that podocytes injury is associated with
reduced autophagy levels during exposure to high glucose. Ursolic acid re-
duces podocytes injury by increasing autophagy through miR-21 inhibition
and PTEN expression.http://dx.doi.org/10.1016/j.hkjn.2015.08.051
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Influence of Shenkang Injection on Hemodynamics of Kidney in Patients
with Early Diabetic Nephropathy
Rao Fu
The first hospital of Harbin City, Harbin, China
Objective: To observe the influence of Shenkang injection on renal artery
peak velocity in systole (Vs) and resistance indices (RI) of patients with early
diabetic nephropathy.
Methods: A total of 58 early diabetic nephropathy patients were randomly
divided into conventional treatment group (A group) and Shenkang Injec-
tion-treated group (B group), 29 cases in each group. To detect the level
of UAER between before and after treatment, color Doppler ultrasound
were used to cheek and analyze the chief renal arteries and intersegmental
arteries Vs and RI of patients. Moreover, 25 healthy subjects were measured
for control.
Results: (1) Vs of patients with early diabetic nephropathy was significantly
lower than that in normal control group, RI was significantly higher than that
in normal control group (P < 0.01). (2) Vs of B group was significantly higher
than that before (P < 0.01), and RI was significantly lower than that before
(P < 0.05). All the improvements were better than those in A group. The A
group had no significant difference with treated before (P > 0.05). UAER of B
group was significantly lower than that before and better than that of A
group (p < 0.01).
Conclusion: Shenkang injection can increase renal artery peak velocity in
systole, decrease resistance indices, improve renal ischemia state, decrease
urine protein, and has curative effect on diabetic nephropathy in earlier
stage.http://dx.doi.org/10.1016/j.hkjn.2015.08.052
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Effect Of Glucagon-like Peptide-1 Receptor Agonists on Regulation of
Blood Pressure and Water-Sodium Metabolism in Rats with Diabetic
Nephropathy
Shaoqing Wang
Chengdu Medical College, Chengdu, China
Objective: To observe the effect of glucagon like peptide-1 receptor
agonist liraglutide on blood pressure and water-sodium metabolism in rats
S18 Diabetic Nephropathywith diabetic nephropathy and investigate the relationship between
glucagon like peptide-1 receptor agonist and the expression of COX2 in renal
medulla.
Methods: 130 male Sprague Dawley rats were divided into the conventional
feed group (normal group, n Z 30) and high sugar and fat diet fed group
(nZ 100) randomly. Diabetic rats were induced by intraperitoneal injection
of streptozotocin after high sugar and fat diets fed eight weeks. The diabetic
rats (nZ 72) divided into the diabetic nephropathy (DN) group, Low-Liraglu-
tide (L-Lg, 5 mg/kg) group and High-Liraglutide (H-Lg, 10 mg/kg) group. To
measure the blood pressure, the level of sodium, 24-hour urinary sodium
(UNa) and 24-hour urinary 6-keto-prostaglandin F1a (6k-PGF1a). Determina-
tion of the expression of COX2 in renal medullary tissue using immunohisto-
chemistry. Using Western blot technology analysis the expression of COX2
protein in the renal medullary.
Results: Compared with N Group, the blood pressure, the serum sodium and
UNa are increasing, the urinary 6k-PGF1a is decreasing, the renal medulla
expression of COX2 is increasing in DN group (P < 0.05). Compared with
the DN group, the blood pressure, the serum sodium and UNa are decreasing,
the urinary 6k-PGF1a is increasing, the renal medulla expression of COX2 is
still increasing in L-Lg group and H-Lg group (P < 0.05). Compared with L-Lg
group, the renal medulla expression of COX2 is further increasing (P < 0.05).
Conclusion: GLP-1 receptor agonist Liraglutide can reduce the blood pres-
sure, the serum sodium, increase the excretion of 24-hour urinary sodium
excretion in DN rats, and increase the excretion of 24-hour urinary 6k-
PGF1a, and upregulate the expression of COX2 protein in the renal medulla.
The mechanism of GLP-1 receptor agonist regulate blood pressure and wa-
ter-sodium metabolism by activation of COX2.http://dx.doi.org/10.1016/j.hkjn.2015.08.053
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Different Doses of Heparin in the Application of Continuous Renal
Replacement Therapy for Diabetic Nephropathy
W. Y. Wang, W. J. Q. Wang, W. W. G. Wang, L. W. Liu, Z. W. J. Zhang
Lanzhou University Second Hospital, Lanzhou, China
Objective: Compare the efficacy and safety of anticoagulation with
different doses of heparin in the continuous renal replacement therapy
(CRRT) for diabetic nephropathy, confirm the effective dose of anticoagu-
lant in the treatment of CRRT for diabetic nephropathy to provide the basic
data for clinical work.
Methods: 54 patients with diabetic nephropathy were randomly divided into
three groups; group 1 (18 patients, heparin, 0.3 mg/kg), group 2 (18 pa-
tients, heparin, 0.4 mg/kg), group 3 (18 patients, heparin, 0.5 mg/kg). To
evaluate coagulation function, the filter and pipeline were observed; the
activated partial thromboplastin time (APTT) and platelet levels were moni-
tored before or after treatment.
Results: In group 1, the APTT and platelet levels had no significant change
after treatment; in group 2, the APTT extended to 1.5 times with no signif-
icant change of platelet levels; in group 3, the APTT raised obviously, other-
wise, the platelet levels decreased remarkable with significance among
group 1, group 2 and group 3 (P < 0.05).
Conclusion: As for diabetic nephropathy, a larger dose of heparin could in-
crease efficacy and safety of CRRT.http://dx.doi.org/10.1016/j.hkjn.2015.08.054
0269
Downregulation of the Expression of PINCH-1 in Kidney Tissue by
Irbesartan in Diabetes Mellitus Rat
Heping Zhang, Xiaohui Liu, Jiangchao Feng, Jie Zhang, Ling Lin
Affiliated Hospital of North Sichuan Medical College, Nanchong, China
Objective: To investigate the effect of irbesartan in regulating the expres-
sion of PINCH-1 in the kidney tissue of diabetes mellitus rat using diabetes
mellitus rat model.
Methods: After establishing rat model of diabetes mellitus, real-time poly-
merase chain reaction (RT-PCR) and Western blot were applied to detect
the expression of PINC-1 in the kidney tissue of diabetes mellitus rat after
irbesartan treatment.Results: RT-PCR shown the PINCH-1 mRNA expression in diabetes mellitus rat
(1.537  0.04) was higher than in the normal rat (1.128  0.03), and
decreased after the treatment of irbesartan (1.246  0.02) (P < 0.05). West-
ern blot showed the expression of PINCH-1 in the kidney tissue of diabetes
mellitus rat with irbesartan treatment (1.159  0.03) (P > 0.05).
Conclusion: Irbesartan could downregulate the expression of PINCH-1 in the
kidney tissue of diabetes mellitus rat.http://dx.doi.org/10.1016/j.hkjn.2015.08.055
0273
Clinical Analysis of Type 2 Diabetes with Proteinuria
X. Z. Zheng
The 211 Hospital of PLA, Harbin, Heilongjiang Province, China
Objective: To analyze the kidney pathogenesis of proteinuria in patients
with type 2 diabetes mellitus.
Methods: Selected 50 cases of type 2 diabetic patients with proteinuria,
all of which were given tests as follows, echocardiography, carotid ultra-
sonography, fundus examination, glomerular filtration rate, renal func-
tion, blood lipids, blood glucose, glycosylated hemoglobin, urine
analysis, 24 hour urinary protein quantitative clinical physical examination
and renal biopsy. According to the pathological results, patients were
divided into diabetic nephropathy group and non-diabetic nephropathy
group.
Results: 48.2% of 50 cases were diagnosed as diabetic nephropathy, while
51.8% were diabetic patients with other glomerular diseases, namely non-
diabetic nephropathy, and in which the highest proportion was focal
segmental glomerulosclerosis. Fasting blood glucose was high in diabetic
nephropathy group (P < 0.05). Cardiac color Doppler ultrasound indicated
that the ejection fraction in the diabetic nephropathy group was signifi-
cantly lower than that in the non-diabetic nephropathy group
(P < 0.05). Carotid artery ultrasonography examination showed that in
diabetic nephropathy group The number of atherosclerotic plaque pa-
tients was significantly higher than that in non-diabetic nephropathy
group, while the intima media thickness (IMT) of the carotid artery in dia-
betic nephropathy group was higher than that in non-diabetic nephropathy
group (P < 0.05). It is worth noting that the non-diabetic nephropathy has
little to do with diabetic retinopathy, which means diabetic retinopathy
has a high sensitivity and specificity for the diagnosis of diabetic nephrop-
athy (P < 0.01).
Conclusion: in the case of type 2 diabetes complicated with urinary protein,
fasting blood glucose, heart shot ejection fraction, carotid atheromatous
plaque and intima-media thickness, and fundus changes could be used as
thereference indexes for the diagnosis of diabetic nephropathy and non-dia-
betic nephropathy, while renal biopsy is an important diagnosis index of dia-
betic kidney disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.056
0281
Clinical and Pathological Predictors of Tubulointerstitial Injury in New
Pathological Classification of Diabetic Nephropathy
Xuejing Zhu1, Xiaofen Xiong1, Shuguang Yuan1, Li Xiao1, Xiao Fu1,
Yuan Yang1, Chengyuan Tang1, Fuyou Liu1, Lin Sun1,2
1Second Xiangya Hospital of Central South University, Changsha, China
2Department of Pathology & Medicine, Northwestern University, Chicago,
Illinois, USA
Objectives: To evaluate the new pathological classification of diabetic
nephropathy (DN) published by Research Committee of the
Renal Pathology Society in 2010 and to investigate clinical and patholog-
ical predictors of tubulointerstitial injury in new pathological
classification.
Methods: 43 cases with DN performed renal biopsy. Patients were
divided into different groups according to glomerular classification
or interstitial fibrosis and tubular atrophy (IFTA) score by the new
pathological classification. We used X2 test or Fisher’s exact test, Mann-
Whitney U-test, Kruskal-Wallis H-test and Spearman’s correlation to make
comparisons and correlations between the clinical and pathological findings
